Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified Health Condition 2: D289- Benign neoplasm of female genitalorgan, unspecified Health Condition 3: N819- Female genital prolapse, unspecified Health Condition 4: D259- Leiomyoma of uterus, unspecified Health Condition 5: C539- Malignant neoplasm of cervix uteri, unspecified Health Condition 6: C402- Malignant neoplasm of long bones of lower limb Health Condition 7: C403- Malignant neoplasm of short bonesof lower limb Hea
Conditions
Interventions
Intervention1: Combined spinal epidural anaesthesia: Group C will receive combined spinal epidural anaesthesia- after placement of epidural catheter and confirmation with test dose 3 ml of lignocaine
Sponsors
Veer Surendra Sai Institute Of Medical Science And Research
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria(all) 1. ASA Grade I & II. 2. Age 20 to 60 years of both sex. 3. Undergoing lower limb and lower abdominal surgeries up to 2 hours.
Exclusion criteria
Exclusion criteria: exclusion criteria(none) 1. Infection at the site of injection 2. Spinal abnormalities 3. Neurological disorders 4. Coagulation disorders 5. Drug allergy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| combined spinal epidural anaesthesia is better in term of onset, duration, efficacy, surgical analgesia, muscle relaxation and hemodynamic response over epidural anaesthesia alone.Timepoint: 1 year | — |
Secondary
| Measure | Time frame |
|---|---|
| Systemic toxicity,adverse effects if any.Timepoint: Will be observed and recorded | — |
Countries
India
Contacts
Public ContactDr Bimal Kishore Panda
Veer Surendra Sai Institute Of Medical Science And Research
Outcome results
None listed